Institute of Clinical Cancer Research Krankenhaus Nordwest (IKF)

Frankfurt 60488

0 studies enrolling now · 1 studies all time

What they study most

Gastric Cancer, Gastroesophageal Junction Cancer, HER2-positive Gastric Cancer

Studies at this site

• Combination Margetuximab, Retifanlimab, Tebotelimab, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer — Completed